EXO-3-(BICYCLO-[2.2.1]-HEPT-5-ENYL)-5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-1H-1,2,4-TRIAZOLE
Compound with spectra: 1 NMR
![EXO-3-(BICYCLO-[2.2.1]-HEPT-5-ENYL)-5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-1H-1,2,4-TRIAZOLE](/api/compound/IHQCAPeIgH5.png?ph=true&h=300&w=458 "EXO-3-(BICYCLO-[2.2.1]-HEPT-5-ENYL)-5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-1H-1,2,4-TRIAZOLE")
| SpectraBase Compound ID | IHQCAPeIgH5 |
|---|---|
| InChI | InChI=1S/C21H16Cl3N3/c22-15-5-3-13(4-6-15)21-25-20(17-10-12-1-2-14(17)9-12)26-27(21)19-8-7-16(23)11-18(19)24/h1-8,11-12,14,17H,9-10H2/t12-,14+,17+/m0/s1 |
| InChIKey | SZAKKKJHBOTUSA-DXCKQFNASA-N |
| Mol Weight | 416.74 g/mol |
| Molecular Formula | C21H16Cl3N3 |
| Exact Mass | 415.040981 g/mol |
| Enantiomer InChIKey | SZAKKKJHBOTUSA-IFIJOSMWSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(5R,6R)-5-Ethyl-1-[(1R)-2-hydroxy-1-phenylethyl]-6-(3-indolyl)-2-piperidone
1-(2,4-dichlorophenyl)-3,5-bis(2-fluorophenyl)-1H-pyrazole
2-(5-bromo-2-hydroxyphenyl)-2,3-dihydro-3-(p-fluorophenyl)-4(1H)quinazolinone
[1,2,4]triazolo[4,3-a]quinoline, 1-(2,4-dimethoxyphenyl)-
acetic acid, [[5-(4-chlorophenyl)-4-phenyl-4H-1,2,4-triazol-3-yl]thio]-, 2-[(E)-(9-ethyl-9H-carbazol-3-yl)methylidene]hydrazide
4-Methoxy-5-morpholino-2-phenyl-1-(o-tolyl)imidazole
6-[(Formyloxy)methyl]-1-(2-methylphenyl)-3-phenyl-1H-pyrazolo[3,4-d]pyrimidine
ethyl 5-(aminocarbonyl)-4-methyl-2-[(9H-xanthen-9-ylcarbonyl)amino]-3-thiophenecarboxylate
{3-Methoxy-2-(N-[3-(4-methoxyphenyl)-1-oxopropynyl]carbomyl)phenyl}-{2-(4-methoxyphenyl)-1-[2-(4-methoxyphenyl)ethyl]-1H-pyrrol-3-yl}methanone
| Title | Journal or Book | Year |
|---|---|---|
| Novel derivatives of 3-alkyl-1,5-diaryl-1H-1,2,4-triazoles and their pharmacological evaluation as CB1 cannabinoid ligands | Monatshefte für Chemie - Chemical Monthly | 2008 |